Please provide your email address to receive an email when new articles are posted on . A systemic sclerosis-related pulmonary hypertension diagnosis in the last 10 years vs. 10 years prior was linked ...
MANCHESTER, England — Use of immunosuppressive drugs within 5 years of the onset of systemic sclerosis (SSc) did not lower patients’ risk for developing pulmonary arterial hypertension (PAH) but was ...
Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ...
The US Food and Drug Administration (FDA) has approved aprocitentan (Tryvio) to lower blood pressure, in combination with other antihypertensive agents, in adults with treatment-resistant hypertension ...
Please provide your email address to receive an email when new articles are posted on . Optometrists should screen all patients for hypertension and offer education on the topic. If the blood pressure ...
Managing hypertension isn't just about what you add to your plate; it’s about the hidden "sodium traps" and inflammatory ...
Opinion - Hypertension is increasing worldwide and has reached epidemic proportions, largely due to modern lifestyle factors. Sedentary work, obesity, lack of physical activity, chronic stress, ...